Biohaven Ltd. (BHVN) Downgraded to Underperform by B of A Securities

Market Context

Biohaven Ltd. operates in the Healthcare sector. The stock currently trades at $14.95 with a market capitalization of $1.2B.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow B of A Securities's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Biohaven Ltd.

Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jun 29, 2026	B of A Securities	Underperform	N/A
May 26, 2026	HC Wainwright & Co.	Neutral	N/A
May 13, 2026	Morgan Stanley	Overweight	N/A
May 05, 2026	RBC Capital	Outperform	N/A
Apr 02, 2026	Citigroup	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View BHVN Stock Page